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Sleep and respiration:
Implications for
pulmonary rehabilitation
Despite the growing interest in the raleof the
inspiratoryand accessorymuscles ofrespiration
in chronic respiratory disease, few therapists
have considered therole sleep may play in the
deteriorationof apatient's clinical condition. A
number of important physiological changes to
respiration occur during sleep, which affect
chest wall mechanics and gas exchange. The
ensuing abnormalities caused by sleep
hypoventilationand fragmentationcan severely
affectdaytimefunction andwellbe ing.
Nocturnal nasal positive pressure ventilation
(NIPPV) isnowestabl ishedas aneffective means
of preventing such changes in patients with
chestwall andlungdisease. Therapists involved
in pulmonary rehabilitation programs must
recognise the potential fornocturnal respiratory
events to severely affect daytime function and
understand the importance of reversing
nocturnal respiratoryfailurein oraefto maximise
the rehabilitation potential of patients.
[Piper AJ: Sleep and respiration: Implications
for pulmonaryrehabilitation. AustralianJournal
ofPhysiotherapy 38: 181-187, 1992]
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raditionally, rehabilitation
programs for patients with
chronic respiratory dysfunction
have emphasised lower extremity
exercise training such as bicycling (Bass
et al 1970), walking (Nicholas et al
1980, Pierce et a11964) or stair
climbing (McGavin et aI1977). The
past 15 years have seen a refocusing of
attention to the area of specific muscle
training (egGross et a11980, Harveret
al 1989,Keensetal 1977,·Leith and
Bradley 1976, Sonne and Davis 1982).
More recently, research has been
directed to the role of the upper limb
and accessory muscles of respiration,
their contribution to ventilation in
chronic disease processes, and the
impact training has on functional
activities (Celli et a11986, Lake et al
1990, Ries et al 1988).
Although the diaphragm has a central
role to play in normal breathing,
accounting for around 70 per cent of
tidal volume (Verschakelenet al 1989),
recruitment of the accessory<muscles of
respiration to augment ventilation is
seen in a variety ofpatients with
pulmonary and. chest wall disease. As
diaphragmatic function is .progressively
impaired, the accessory muscles must
increase their participation in
respiration in order to maintain
effective ventilation. These muscles
then become an essential part of the
respiratory pump. It has been
proposed that selective strength and
endurance training of the accessory
muscles may improve respiratory
performance in patients with
pulmonary dysfunction (Criner 1991).
Despite this interest in the diaphragm
and accessory respiratory muscles
during rest.and activities of daily living,
few clinicians have considered the
impact sleep may have on breathing
and respiratory muscle performance,
particularly in the context of
pulmonaryrehabilitation. The
contribution of sleep disordered
breathing to the patient's overall
clinical condition may be significant,
resulting in a more rapid progression
of the patient's disease than might
otherwise be expected.
Sleep and V,entilation
A number ofimportant physiological
changes to respiration occur during
sleep. Although these are normal
events, .they may have considerable
impact on those patients with pre...
existing lung or chest wall dysfunction.
Inmost instances, preparation for
sleep involves lying down. In such a
position, the abdominal contents move
upwards under the diaphragm,
reducing the functional residual
capacity (FRC) and potentially
worsening ventilation perfusion
mismatch (Hudgel etal 1984). Craig et
al (1971) found that there was a fall in
volume in most lung function
parameters associated with a change to
the supine position, including a
reduction in FRC and an increased
likelihood of airway closure in
dependent zones. As is clinically
observed in those patients whose
Figure 1.
Recording of arterial oxygen saturation (solid line) and transcutaneous carbon dioxide
(broken line) ina 11 year-old-male with Duchennemuscular dystrophy. Panel A: Without
ventilatory support there is marked nocturnal hypoventilation and CO2 retention. Panel B:
A repeat sleep study four months later demonstrated that NIPPV was effective throughout
the night, keepingS
a
02 0reater than 95 per cent and maintaining CO2 within the normal
range.
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respiratory function in the upright
position is already compromised,
adoption of the recumbent position
further reduces oxygen saturation and
can cause marked dyspnoea and
distress. During REM sleep, a further
fall inFRC occurs, accompanied by a
decrease in S302 which, although
modest in normal subjects,may
become clinically significant in patients
with respiratory disease, as extensive
airway closure and intrapulmonary
shunting occurs (HudgeLand
Devadatta 1984, Muller et a11980). In
addition, a small degree of
hypoventilation occurs during sleep,
particularly in the deeper stages (called
rapid-eye-movement or REM sleep),
even in the normal population
(Douglaset al 1982). The decrease in
ventilation is due to a reduction in
ventilatory drive with loss of the
wakefulness stimulus (Douglas 1985).
As a result, alveolar ventilation is
reduced, with a fall in P30 2 of 4-
9mmHg and an in~rease in P3CO2 of
up to 7mmHg durIng non REM sleep
and slightly larger changes in REM
sleep (Burlow·1963, Douglas 1982).
Although a normal phenomenon, the
effects will be exaggerated in those
patients with pre-existing pulmonary
dysfunction, and may be of
considerable importance for those
already on the steep portion of the
oxyhaemoglobin dissociation curve.
Ventilatory responses to chemical
stimuli, such as hypoxia and
hypercapnia, are reduced during sleep,
especially in REM sleep (Berthon
Jones and Sullivan 1982, 1984).
Hence, during sleep, the body's normal
defence mechanisms to
hypoventilation are impaired,allowing
lower levels of oxygen and higher
levels of carbon dioxide to be tolerated.
Patients in whom diaphragm function
is impairedwill·rely on the ·activation
of their accessory inspiratory muscles
to generate sufficient inspiratory
pressure to maintain effective
ventilation. However, generalised
postural muscle hypotonia occurs
during sleep, being most profound
during periods ofREM sleep
(Remmers 1981, Tusiewicz et aI1977).
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The diaphragm is relatively unaffected
by this inhibition, but those muscle
groups with a dual respiratory and
p~ostural function such as the
intercostals, shoulder girdle and
sternomastoid muscles will
substantially reduce activity. Severe
ventilatory deterioration is likely to
occur, therefore, in patients who rely
on the accessory respiratory muscles to
maintain ventilation, since a vital part
of their respiratory pump is lost during
REM sleep.
In patients with lung diseases such as
cystic .fibrosis and chronic airflow
limitation, the accessory muscles of the
chest wall play an additional role in gas
exchange and respiration by elevating
end expiratory lung volume, thereby
preventing small airway closure.
During REM sleep, with loss of this
accessory muscle activity, end
expiratory lung volume decreases,
contributing to an even greater
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deterioration in gas exchange through
ventilation perfusion mismatching
Gohnson and Remmers 1984, Muller
etaI1980). _
Nocturnal hypoventilation may occur
in patients with disease processes
affecting the chest wall, .diaphragm,
lungs or respiratory control centres.
Respiratory failure .occurring
predominately at night may go
unrecognised for some time despite the
presence of daytime symptoms such as
breathlessness, hypersomnolence,
morning headaches and memory
difficulties. Such .symptoms can be
mistaken for a progression of the
primary disease process, and in the past
it has been considered inappropriate to
further intervene in these patients
(Elliset aI1988).
The inability to maintain nocturnal
ventilation appears first in REM sleep
(Bye et al1990).Normally REM sleep
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accounts for 20-25 percent of total
sleep time (Carskadon and Dement
1989). However, with ongoing REM
fragmentation from repeated oxygen
desaturation and arousals, there is
increasing pressure on the body to try
to attain this sleep state. With longer
periods in or attempting REM sleep,
the patient is exposed to longer periods
of disordered breathing. The
chemoreceptors are subjected to
progressively lower levels of oxygen
and higher levels of carbon dioxide,
which leads eventually to reduced
chemosensitivity. In addition, the
ongoing fragmentation of sleep will
depress arousal responses, permitting
more severe abnormalities in
ventilation to occur before the body
responds. With progressive adaptation
to these events, the drive to breathe is
depressed, .and so the downward spiral
continues. Eventually, the inability to
maintain ventilation becomes apparent
during the day, manifesting in CO2
retention.
It is now well established that regular
nocturnal nasal ventilation (NIPPV) in
patients with sleep hypoventilation and
respiratory .failure can dramatically
improve daytime arterial blood gas
tensions, exercise tolerance and quality
of life (Bach and Alba 1990, Ellis· et al
1987, Ellis et al 1988, Kerby et aI,
1987). The precise mechanism by
which such clinical improvement
occurs remains unclear, ·but it is likely
to be multifactorial. ·Carreyet al
(1990) found that during nasal
ventilation, significant reductions in
inspiratory muscle activity were
achieved. They concluded that
NIPPV maybe useful in improving
ventilatory performance by resting the
inspiratory muscles. However, the
improvement in nocturnal gas
exchange which occurs withNIPPV
probably plays a more important role.
In the presence of hypercapnia,
hypoxia and acidosis, respiratory
muscle function is severely
compromised (Esau 1989,]ardimetal
1981, Juan et 1984), reducing
diaphragm contractility and inducing
lower thresholds for fatigue.
Improvement in the biochemical
environment in which the respiratory
ORIGINAL ARTICLE
Figure 2.
Serial PeC02 measurements in the 29-year-
old man with cystic fibrosis (Case 3), in the
months prior to and after commencing
NIPPV. The patients's PaC02 remains in the
58-59mmHg range after two years of
nocturnaIventilati011.
muscles must work during sleep could
be expected to lead to improvements in
daytime function and respiratory
muscle performance. Restoration of
normal sleeping patterns by preventing
sleep fragmentation may also. improve
daytime function and cognitive
processes ..
In order to properly evaluate sleep
and the type ofhreathing disorders
which may be occurring nocturnally,
a full diagnostic sleep study is
necessary. During this investigation a
number of physiological parameters
are recorded.. Sleep stages (NREM
and REM) are determined from
electroencephalogram (EEG), electro-
oculogram (EOG) and submental
electromyogram (EMG) recordings.
Continuous monitoring of airflow,
chest wall and abdominal movements,
oxygen saturation and transcutaneous
carbon dioxide permit determination
of the presence and nature of
respiratory abnormalities.
NIPPV involves useofa portable
volume or time cycled ventilator which
has been specifically designed for home
use (for examplePLV 100, Lifecare,
Colorado). To this a comfortable,
easily applied nasalCPAP mask is
attached. If necessary, oxygen can be
added via a port in the mask. In the
examples discussed later, only patient 3
required supplemental oxygen whilst
on NIPPV. The machine,is set in the
assist!control mode, and other
parameters such as tidal volume,
inspiratory time and rate are set
initially·for patient comfort. As
tolerance of the machine increases,
adjustments are made to maximise
alveolar ventilation. A number of
machines are designed so that positive
end expiratory pressure (PEEP) can be
added to the expiratory port of the
breathing circuit. This is useful for
patients who demonstrate upper airway
obstruction in addition to
hypoventilation.
The following case reports illustrate
the variety of ways in which patients
with nocturnal respiratory failure can
present. The use of NIPPV in such
cases, both as short and long term
therapy, is also discussed.
Case reports
Case 1.
A 17-year-old male with advanced
Duchenne muscular dystrophy was
referred for investigation of dyspnoea
during speech. He denied any
tiredness, sleepiness or breathlessness.
He had been wheelchair bound for
several years. On examination, he was
found to be emaciated and using the
accessory muscles of respiration during
tidal breathing. There was a fall in
vital capacity from 350mlswhile sitting
to 200mls while supine. Maximum
inspiratory and expiratory mouth
pressures were severely reduced
(14cmH20 or 20 per cent predicted
and 18cmH20 or l4 per cent predicted
respectively), reflecting extreme
respiratory muscle weakness. Arterial
blood gas tensions were abnormal with
a PaC02 of 67mmHg and PaOZ of
61mmHg. Overnight. monitoring of
SaOLand T
c
C02 showed baseline
saturation of 70 percent in NREM
sleep. Further drops occurred during
REM periods, down as low as 34 per
cent, associated with hypoventilation
and loss ofaccessory muscle activity
(Figure la). Blood gases taken on
awakening showed a rise in PaCO2 to
78mmHganda fall in Pa02 to
49mmHg. He was started on NIPPV
..
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and sent home. VVhen reviewed at
four months he was noticeably more
talkative, with the family reporting a
marked change in mood. They found
him to be brighter, more alert and
participating more in family life. A
repeat sleep study on the ventilator
showed considerable improvement in
oxygen satura~on.anda marked
reduction in T
c
C02(Figure Ib).
These changes were being maintained
during the day with a PaC02 of
49mmHg and P
a
0 2of 79mmHg. One
year later, he continues to do well on
nocturnal nasal ventilation.
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Figure 3.
Slow recording of 5
a
02 and icC02 ina 38-year-o!d man with kyphoscoliosis (Case 4).
Section A shows the first REM period of the night-Section B illustrates the last portion of
the~ight, prior to awakening. Note the gradual decline in saturation baseline (solid line)
over the night, and the corresponding rise in TcC02-
Case 2.
A 45-year-old male was referred to the
Sleep Unit with a seven~year history of
trunk muscle weakness diagnosed as
Acid Maltase disease. For the previous
four years, he had noticed increased
difficulty exercising because of
breathlessness. On presentation,he
was experiencing unpleasant morning
headaches, frequent· nocturnal
awakenings and daytime somnolence.
He complained ofworsening memory
and difficulty concentrating, so much
so that his business was at risk of
collapsing because of poor decision
making..Daytime arterial blood gas
tensions showed a PaCOzof 49mmHg
and a Pa02 of 74mmHg. Alilung
volumes were around 60 per cent of
predicted values. Sleep studies were
performed and showed periods of
hypoventilationinREM sleep with
arterial oxygen desaturation to 60 per
cent. These episodes were associated
with marked carbon dioxide retention
and bradycardia. He was started on
nocrurnalNIPPV with resulting
amelioration of all daytime symptoms.
Four years later, his arterial blood gas
tensions remain normal with a P
a
C02
of 44mmHg and a Pa02 of 90mmHg.
Improved daytime function coincided
with an upturn in his business.
Case 3.
A 29-year-old man with cystic fibrosis
presented with increasing dyspnoea,
cough and sputum. In the previous 18
months he had required increasingly
frequent admissions to hospital for
exacerbations of his lung disease. He
had been on continuous home oxygen
therapy for two years. His respiratory
function had showed a .steady decline
over this period and, at presentation,
he had a FEV1 of 11 per cent of
predicted and ·achronically.high
daytime PaCO2in the mid .to high 70s.
Despite maximum conventional
therapy, the patient continued to
deteriorate and, with steadily rising
CO2levels, became increasingly
drowsy and difficult to arouse.
BOecause of this, active involvement
with respiratory physiotherapy was
minimal. The decision to commence
NIPPV was made after he failed to
tolerate nasalCPAP. Within three
days ofNIPPV treatment the patient
showed signs of improvement,with
less dyspnoea, disappearance of
morning headaches, and increased
tolerance to therapeutic manoeuvres
such as postural drainage and
percussion. With this improving
clinical state, he was able to cough and
clear secretions more effectively. He
reported sleeping better and awaking
feeling more refreshed. Over the next
two weeks PaCOzlevelsbegan to fall
(Figure 2). Shortly afterwards, he was
assessed by the heart-lung transplant
team and accepted into the program.
He has continued on NIPPV now for
two years, while awaiting
transplantation; During this time his
condition, though still end-stage, has
remained stable with a daytime PaC02
in the range 58-59mmHg.
Case 4.
A 70-year-old man with CAL from
cigarette smoking and kyphoscoliosis
had heenmanaged successfully with
nocturnalnasalCPAP and oxygen for
four years, after overnight sleep studies
had demonstrated upper airway
obstruction during REM, and drops in
oxygen saturation to 50 per cent.
However, in the previous 12 months
he had been experiencing deteriorating
functional capacity and worsening
arterial blood gas tensions. He had
been started on a supervised
pulmonary rehabilitation program
some months earlier. Breathlessness,
morning headaches and lethargy were
severely affecting his quality of life.
Three months earlier, his bedroom
and a bathroom had been relocated to
the ground floor of his home ashe was
no longer able to manage stairs. He
was transferred to hospital and
commenced on nocturnal NIPPV for a
10-day period. Within two days, his
breathlessness and fatigue had
subjectively improved. After 10 days of
intervention he was maintaining a
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figure 4.
Overnight Sa02 and TcC02 recording in Patient 6, thefive~year-old boy with central
hypoventilation. The patient was initially studied off the ventilator but at sleep onset, the
TcC02 began to rise steadily with a corresponding fallon Sa02• After NIPPV was
commenced, CO2 returned quickly to within normal rsngeand the Sa02was maintained at
greater than 95 per cent.
These case studies serve to illustrate
the way in which nasal ventilation used
only during sleep can be an effective
method of management for a range of
patients presenting with chronic
respiratory failure. It is unlikely that
these patients would have improved to
the same extent with a more traditional
approach to treatment and
rehabilitation. Indeed, for many
patients with severe chest wall,
neuromuscular or lung disease,
hypercapnic respiratory failure has
frequently been seen as the inevitable
pre-terminal event. As a consequence,
vigorous intervention has not always
been considered appropriate in the end
stages of the disease (Elliset aI1988).
In addition, the clinical condition of
such patients is so extreme that they
are frequently unable to participate in,
let alone benefit from, a rehabilitation
program. For patients with chronic
found cyanosed and unresponsive with
dilated pupils. His PaCO2at this time
was 89mmHg. He was intubated,
ventilated and transferred to the
Children's Hospital where he
underwent adenotonsillectomye
Despite this, severe central
hypoventilation .continued and he
remained intubated for three weeks.
Any attempt to wean him from the
ventilator resulted in marked drops in
0z saturation and rises in COz levels to
the 75-85mmHg range during sleep,
and tracheostomy was considered. A
trial of NIPPV was commenced with
dramatic improvement in daytime
PaC01 to within the normal range and
control of hypoventilation at night. A
repeat sleep study off the ventilator
two months later demonstrated
persisting central hypoventilation
resulting in the rapid development of
respiratory acidosis (from a pH of7.40
when awake to 7.17 when asleep) and
COz retention (from 34mmHg awake
to 65mmHgasleep) within 30 minutes
ofsleep onset (Figure 4)~ ·He has
continued on nocturnal NIPPV at
home for 12 months, returning to
kindergarden,·with no residual daytime
or nocturnal problems.
Discuss<ion
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muscle EMG activity.NIPPV was
commenced, with marked
improvement in daytime symptoms. A
repeat sleep study demonstrated that
on the ventilator, oxygen saturation
was kept above 95 per <cent and carbon
dioxide levels remained within the
normal range. ·Daytime blood gases
also improved, with the patient
maintaining a pH of 7.39, P
a
O2 of
80mmHg and a PaCOZ of43mmHg.
vVhen reviewed at six months, he
reported the disappearance of early
morning headaches, and the use of the
ventolin puffer just once since
commencing ventilation. He has
continued at home on nocturnal
NIPPVand remains well 18 months
later.
Case 6.
A five-year-old boy was referred to the
program with a history suggestive of
chronic upper airway obstruction with
a central respiratory drive defect. His
mother reported a 12-month history of
nocturnal apneic episodes associated
with upper respiratory tract infections.
Duringone.such episode he required
admission to hospital because of
cyanotic periods at night. He was
noted to desaturate to 55 per cent and
was commenced on. oxygen via nasal
prongs~ Several hours later he was
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daytime CO2 lOmmHg below his
normal· chronic value, and inspiratory
mouth pressures had improved slightly
from 40cmH 0 to 55cmH 0 without
any appeciable change in &is lung
volumes. Most importantly from this
man's point of view, he awoke feeling
refreshed and without dehilitating
headaches. His exercise tolerance
improved from 60m to 480m. His stair
climbing ability also improved. He was
restarted on nasal CPAP and returned
home, where he remained
symptomatically improved when
reviewed four months later.
Case 5.
A 38-year-old man with severe
kyphoscoliosis presented with a three-
year history of increasing shortness of
breath, and a six-month history of
severe morning headaches. He was
experiencing recurrent chest infections
and had required hospitalisation twice
in the previous 12 months. He was
taking ventolin two puffs four times a
day. Daytime arterial blood gas
tensions were pH 7.35, P
a
C02
48mmHg and Pa0264mmHg.
Overnight monitoring·showed marked
REM desaturation to a minimum of 30
per cent with concurrent rises in
TcCOz (Figure 3). These periods were
associated with loss of accessory
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respiratory failure who demonstrate
nocturnal hypoventilation, NIPPV can
improve daytime blood gas tensions
and alleviate the disabling daytime
symptoms of sleep disordered
breathing. As a consequence of
improved daytime function, including
better mentation, increased work
capacity, and normalisation ofpca
levels, involvement in rehabilitation 2
programs can be facilitated. However,
once on NIPPV, many patients require
no further formalised rehabilitation as
the improvements achieved with '
nocturnal ventilation permit them to
resume a normal life, including return
to work or study.
Chronic adaption to nocturnal
hypoventilation results in the control
of breathing becoming ineffective even
when awake, and manifests as CO
retention. By maintaining arterial
2
blood gas tensions within the normal
range with NIPPV, the sensitivity of
the respiratory centre can be restored
(Garay et aI1981). The improvements
seen in daytime levels of CO after
intervention withNIPPV ar~ much
greater than that reported in the
literature after using other exercise and
rehabilitation techniques in patients
with chronic pulmonary dysfunction
(Ellis et a11988, Ellis 1991, Foster et al
1988).
It appears that, at least for some
patient groups, nocturnal NIPPV can
also achieve improvements in
respiratory muscle function equal to or
greater than is currently the case with
more traditional approaches to
pulmonary rehabilitation (Ellis 1991,
Goldsteinet aI1991). Smith (1988)
cautioned against the use of respiratory
muscle training in patients with severe
neuromuscular disease, as such training
could potentially push patients closer
to their fatigue threshold. Golstein
and colleagues (1991) usedNIPPV in a
group of patients with restrictive
ventilatory failure, all of whom were
too unstable to participate initially in a
rehabilitation program. Reasons for
this included refactory cor pulmonale,
chronic fatigue or daytime
somnolence. These authors found
nocturnal ventilatory support to be
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crucial in maximising the patient's
clinical condition, exercise tolerance
and sense ofwellbeing. Their results
parallel the experience provided in the
case reports and previously reported
results inpatients with end-stage cystic
fi~rosis awaiting heart lung transplant
(Plperet aI1990). These patients
were deteriorating despite maximum
conventional therapy. Introduction
of nasal ventilation stabilised the
patient's condition, improved sleep
quality and lessened the degree of
hypercapnia. In those patients
where it was appropriate, tolerance
to physiotherapeutic procedures
including participation in a
rehabilitation program was improved.
The increased sense of wellbeing
resulted in improved functional status
and psychosocial benefits.
Conclusion
Any form of rehabilitation for patients
with respiratory dysfunction should be
directed towards achieving the
maximal functional improvement
possible in the patient, whilst
stabilising the disease process.
Consideration must also be given to
the role abnormal nocturnal gas
exchange and sleep fragmentation is
playing in the patient's disease
progression. When considering
treatment options, therapists need to
weigh the balance between
overworking already fatigued or
weakened muscles and preventing
disuse atrophy caused by inactivity.
However, the full benefits of whole
body, or specific respiratory or
accessory muscle training may be
masked by severe· respiratory
inadequacy occurring at night,which
affects daytime performance. Nasal
ventilation allows the clinician to
combine rest of the respiratory muscles
with exercise in a noninvasive and
simple way, which may afford the
patient greater clinical improvements
than the use of any single technique.
The current focus in pulmonary
rehabilitation is accessory muscle
function and·training. This view needs
to be broadened to begin to consider
che~twall mechanics and gas exchange
durIng sleep, and the role primary and
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ac~essory respiratory muscles playin
thIS setting. Recognising the potential
for nocturnal respiratory events to
dramatically affect daytime function
and wellbeing will assist the quest to
maximise the rehabilitation potential
and quality of life ofsuch patients.
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